by GlobeNewsWire | Oct 13, 2016 | Globe Newswire
[nextpage title=”Press Release” ] TORONTO, Oct. 13, 2016 (GLOBE NEWSWIRE) — Cynapsus Therapeutics Inc. (“Cynapsus”) (NASDAQ:CYNA) (TSX:CTH), a specialty central nervous system pharmaceutical company developing a fast-acting, easy-to-use, sublingual...
by GlobeNewsWire | Oct 13, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., Oct. 13, 2016 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (Nasdaq:CYTK) today announced that it is scheduled to report third quarter results on Thursday, October 27, 2016 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics’...
by GlobeNewsWire | Oct 13, 2016 | Globe Newswire
[nextpage title=”Press Release” ] Phase 1/2 Study Expected to Resume by End of 2016 Requirement for Prophylactic Corticosteroids Removed SAN RAFAEL, Calif., Oct. 13, 2016 (GLOBE NEWSWIRE) — BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today...
by GlobeNewsWire | Oct 13, 2016 | Globe Newswire
BRISBANE, Calif., Oct. 13, 2016 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic surveillance solutions for transplant...
by GlobeNewsWire | Oct 13, 2016 | Globe Newswire
MAYNARD, Mass., Oct. 13, 2016 (GLOBE NEWSWIRE) — Acacia Communications, Inc. (NASDAQ:ACIA), a leading provider of high-speed coherent optical interconnect products, today announced the closing of its follow-on public offering of 4,500,000 shares of its common...